Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Newglim MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Helianthus Lifesciences Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Newglim MV 2mg/500mg/0.2mg Tablet

Diabetol-Combo 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes to manage blood glucose levels. Diabetol-Combo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive treatment plan encompassing diet modification, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Newglim MV 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Newglim MV 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Newglim MV 2mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Newglim MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Newglim MV 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Newglim MV 2mg/500mg/0.2mg tablets on an empty stomach.

How Newglim MV 2mg/500mg/0.2mg Tablet works:

Each Newglim MV tablet (2mg/500mg/0.2mg) contains a triple-action antidiabetic formula.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Newglim MV 2mg/500mg/0.2mg tablets with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Newglim MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Newglim MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Newglim MV 2mg/500mg/0.2mg Tablets in individuals with kidney impairment carries a significant risk and is best avoided. Medical advice is recommended. Furthermore, this medication is contraindicated for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Individuals with liver impairment should use Newglim MV 2mg/500mg/0.2mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Newglim MV 2mg/500mg/0.2mg Tablet :

Should you forget to take a Newglim MV 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Newglim MV 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Newglim MV 2mg/500mg/0.2mg Tablet

Newglim MV 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Newglim MV 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, skin rash, and respiratory infection.
Newglim MV 2mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any ingredient or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Newglim MV 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Newglim MV 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Newglim MV 2mg/500mg/0.2m...
128
MRP 156
17% off